Literature DB >> 29124295

[Novel concepts for eradication of biofilms on implants].

Susanne Feihl1, Nora Renz2, Andrej Trampuz2.   

Abstract

Mesh:

Year:  2017        PMID: 29124295     DOI: 10.1007/s00113-017-0437-8

Source DB:  PubMed          Journal:  Unfallchirurg        ISSN: 0177-5537            Impact factor:   1.000


× No keyword cloud information.
  4 in total

1.  Efficacy and safety of rifampin containing regimen for staphylococcal prosthetic joint infections treated with debridement and retention.

Authors:  O C El Helou; E F Berbari; B D Lahr; J E Eckel-Passow; R R Razonable; I G Sia; A Virk; R C Walker; J M Steckelberg; W R Wilson; A D Hanssen; D R Osmon
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-05-27       Impact factor: 3.267

2.  Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group.

Authors:  W Zimmerli; A F Widmer; M Blatter; R Frei; P E Ochsner
Journal:  JAMA       Date:  1998-05-20       Impact factor: 56.272

3.  Killing of nongrowing and adherent Escherichia coli determines drug efficacy in device-related infections.

Authors:  A F Widmer; A Wiestner; R Frei; W Zimmerli
Journal:  Antimicrob Agents Chemother       Date:  1991-04       Impact factor: 5.191

4.  Generation of Persister Cells of Pseudomonas aeruginosa and Staphylococcus aureus by Chemical Treatment and Evaluation of Their Susceptibility to Membrane-Targeting Agents.

Authors:  Lucia Grassi; Mariagrazia Di Luca; Giuseppantonio Maisetta; Andrea C Rinaldi; Semih Esin; Andrej Trampuz; Giovanna Batoni
Journal:  Front Microbiol       Date:  2017-10-04       Impact factor: 5.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.